Applied Materials To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 12/02 14:38
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Guggenheim raised Mongodb Inc (NASDAQ:MDB) price target from $400 to $450. Guggenheim analyst Howard Ma maintained a Buy rating. Mongodb shares closed at $328.87 on Monday. See how other analysts view this stock.
- B of A Securities raised the price target for XPO Inc (NYSE:XPO) from $151 to $158. B of A Securities analyst Ken Hoexter maintained a Buy rating. XPO shares closed at $143.43 on Monday. See how other analysts view this stock.
- JP Morgan raised Formula One Group (NASDAQ:FWONK) price target from $120 to $122. JP Morgan analyst David Karnovsky maintained an Overweight rating. Formula One Group shares closed at $94.80 on Monday. See how other analysts view this stock.
- Keybanc increased the price target for Applied Materials Inc (NASDAQ:AMAT) from $240 to $285. Keybanc analyst Steve Barger maintained an Overweight rating. Applied Materials shares closed at $254.75 on Monday. See how other analysts view this stock.
- B of A Securities boosted the price target for Credo Technology Group Holding Ltd (NASDAQ:CRDO) from $165 to $240. B of A Securities analyst Vivek Arya maintained a Buy rating. Credo Technology shares closed at $171.13 on Monday. See how other analysts view this stock.
- Barclays increased Johnson & Johnson (NYSE:JNJ) price target from $176 to $197. Barclays analyst Matt Miksic maintained an Equal-Weight rating. Johnson & Johnson shares settled at $205.34 on Monday. See how other analysts view this stock.
- Baird raised Albemarle Corp (NYSE:ALB) price target from $81 to $113. Baird analyst Ben Kallo upgraded the stock from Underperform to Neutral. Albemarle shares closed at $128.33 on Monday. See how other analysts view this stock.
- Guggenheim increased Universal Health Services Inc (NYSE:UHS) price target from $253 to $274. Guggenheim analyst Jason Cassorla maintained a Buy rating. Universal Health shares closed at $239.43 on Monday. See how other analysts view this stock.
- Cantor Fitzgerald cut the price target for Janux Therapeutics Inc (NASDAQ:JANX) from $200 to $150. Cantor Fitzgerald analyst Josh Schimmer maintained an Overweight rating. Janux Therapeutics shares settled at $33.99 on Monday. See how other analysts view this stock.
- TD Cowen raised Darling Ingredients Inc (NYSE:DAR) price target from $34 to $45. TD Cowen analyst Jason Gabelman upgraded the stock from Hold to Buy. Darling Ingredients shares closed at $36.77 on Monday. See how other analysts view this stock.
Considering buying AMAT stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2025 Webull. All Rights Reserved